8 results on '"Díaz-Maroto, J. L."'
Search Results
2. Erratum to: Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project)
- Author
-
Rivero-Calle, I, Pardo-Seco, J, Aldaz, P, Vargas, D A, Mascarós, E, Redondo, E, Díaz-Maroto, J L, Linares-Rufo, M, Fierro-Alacio, M J, Gil, A, Molina, J, Ocaña, D, Martinón-Torres, Federico, and NEUMOEXPERTOS group
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Primary care ,Medical Records ,Young Adult ,Community-acquired pneumonia ,Metabolic Diseases ,Risk Factors ,Agency (sociology) ,medicine ,Prevalence ,Humans ,Risk factor ,Life Style ,Aged ,Retrospective Studies ,Aged, 80 and over ,Primary Health Care ,business.industry ,Incidence (epidemiology) ,Developed Countries ,Incidence ,Subject (documents) ,Pneumonia ,Middle Aged ,medicine.disease ,Community-Acquired Infections ,Infectious Diseases ,Cardiovascular Diseases ,Spain ,Family medicine ,Female ,Erratum ,business - Abstract
Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality in adults even in developed countries. Several lifestyle factors and comorbidities have been linked to an increased risk, although their prevalence has not been well documented in the primary care setting. The aim of this study is to assess the incidence, risk factor and comorbid conditions distribution of CAP in adults in primary care in Spain.Retrospective observational study in adults (18 years-old) with CAP diagnosed and attended at primary care in Spain between 2009 and 2013, using the Computerized Database for Pharmacoepidemiological Studies in Primary Care (BIFAP).Twenty-eight thousand four hundred thirteen patient records were retrieved and analyzed. Mean age (standard deviation): 60.5 (20.3) years, 51.7 % males. Global incidence of CAP in adults was estimated at 4.63 per 1000 persons/year. CAP incidence increased progressively with age, ranging from a 1.98 at 18-20 years of age to 23.74 in patients over 90 years of age. According to sex, global CAP incidence was slightly higher in males (5.04) than females (4.26); CAP incidence from 18 to 65 year-olds up was comparable between males (range: 2.18-5.75) and females (range: 1.47-5.21), whereas from 65 years of age, CAP incidence was noticeable higher in males (range: 7.06-36.93) than in females (range: 5.43-19.62). Average prevalence of risk factors was 71.3 %, which increased with age, doubling the risk in males by the age of 75 (females 20 % vs males 40 %). From 55 years of age, at least one risk factor was identified in 85.7 % of cases: one risk factor (23.8 %), two risk factors (23.4 %), three or more risk factors (38.5 %). Major risk factors were: metabolic disease (27.4 %), cardiovascular disease (17.8 %) and diabetes (15.5 %).The annual incidence of CAP in primary care adults in Spain is high, comparable between males and females up to 65 years of age, but clearly increasing in males from that age. CAP risk increases with age and doubles in males older than 75 years. The majority of CAP cases in patients over 55 years of age is associated to at least one risk factor. The main risk factors associated were metabolic disease, cardiovascular disease, and diabetes.
- Published
- 2017
3. Differences between diabetic and non-diabetic patients with community-acquired pneumonia in primary care in Spain.
- Author
-
Arias Fernández, Loreto, Pardo Seco, Jacobo, Cebey-López, Miriam, Gil Prieto, Ruth, Rivero-Calle, Irene, Martinon-Torres, Federico, Gil de Miguel, Ángel, Martinón-Torres, F., Vargas, D., Mascarós, E., Redondo, E., Díaz-Maroto, J. L., Linares-Rufo, M., Gil, A., Molina, J., Ocaña, D., Rivero-Calle, I., and NEUMOEXPERTOS group
- Subjects
MEDICAL personnel ,COMMUNITY-acquired pneumonia ,PRIMARY care ,PARKINSON'S disease ,COMORBIDITY - Abstract
Background: Diabetes is one of the underlying risk factors for developing community-acquired pneumonia (CAP). The high prevalence of diabetes among population and the rising incidence of this illness, converts it as an important disease to better control and manage, to prevent its secondary consequences as CAP. The objective of this research is to describe the characteristics of the patients with diabetes and the differences with the no diabetes who have had an episode of CAP in the context of the primary care field.Methods: A retrospective, observational study in adult patients (> 18 years-old) who suffer from CAP and attended at primary care in Spain between 2009 and 2013 was developed using the Computerized Database for Pharmacoepidemiological Studies in Primary Care (BIFAP). We carried out a descriptive analysis of the first episodes of CAP, in patients with or without diabetes as comorbidity. Other morbidity (CVA, Anaemia, Arthritis, Asthma, Heart disease, Dementia, Depression, Dysphagia, Multiple sclerosis, Epilepsy, COPD, Liver disease, Arthrosis, Parkinson's disease, Kidney disease, HIV) and life-style factors were also included in the study.Results: A total of 51,185 patients were included in the study as they suffer from the first episode of CAP. Of these, 8012 had diabetes as comorbidity. There were differences between sex and age in patients with diabetes. Patients without diabetes were younger, and had less comorbidities including those related to lifestyles such as smoking, alcoholism, social and dental problems than patients with diabetes.Conclusions: Patients who developed an episode of CAP with diabetes have more risk factors which could be reduced with an appropriate intervention, including vaccination to prevent successive CAP episodes and hospitalization. The burden of associated factors in these patients can produce an accumulation of risk. Health care professional should know this for treating and control these patients in order to avoid complications. Diabetes and those other risk factors associated could be reduced with an appropriate intervention, including vaccination to prevent the first and successive CAP episodes and the subsequent hospitalization in severe cases. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
4. Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project).
- Author
-
Rivero-Calle, I., Pardo-Seco, J., Aldaz, P., Vargas, D. A., Mascarós, E., Redondo, E., Díaz-Maroto, J. L., Linares-Rufo, M., Fierro-Alacio, M. J., Gil, A., Molina, J., Ocaña, D., and Martinón-Torres, Federico
- Subjects
COMMUNITY-acquired pneumonia ,DISEASE prevalence ,PUBLIC health ,DISEASE risk factors - Abstract
Background: Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality in adults even in developed countries. Several lifestyle factors and comorbidities have been linked to an increased risk, although their prevalence has not been well documented in the primary care setting. The aim of this study is to assess the incidence, risk factor and comorbid conditions distribution of CAP in adults in primary care in Spain. Methods: Retrospective observational study in adults (≥18 years-old) with CAP diagnosed and attended at primary care in Spain between 2009 and 2013, using the Computerized Database for Pharmacoepidemiological Studies in Primary Care (BIFAP). Results: Twenty-eight thousand four hundred thirteen patient records were retrieved and analyzed. Mean age (standard deviation): 60.5 (20.3) years, 51.7% males. Global incidence of CAP in adults was estimated at 4.63 per 1000 persons/year. CAP incidence increased progressively with age, ranging from a 1.98 at 18-20 years of age to 23.74 in patients over 90 years of age. According to sex, global CAP incidence was slightly higher in males (5.04) than females (4.26); CAP incidence from 18 to 65 year-olds up was comparable between males (range: 2.18-5.75) and females (range: 1.47-5.21), whereas from 65 years of age, CAP incidence was noticeable higher in males (range: 7.06-36.93) than in females (range: 5.43-19.62). Average prevalence of risk factors was 71.3%, which increased with age, doubling the risk in males by the age of 75 (females 20% vs males 40%). From 55 years of age, at least one risk factor was identified in 85.7% of cases: one risk factor (23.8%), two risk factors (23.4%), three or more risk factors (38.5%). Major risk factors were: metabolic disease (27.4%), cardiovascular disease (17.8%) and diabetes (15.5%). Conclusions: The annual incidence of CAP in primary care adults in Spain is high, comparable between males and females up to 65 years of age, but clearly increasing in males from that age. CAP risk increases with age and doubles in males older than 75 years. The majority of CAP cases in patients over 55 years of age is associated to at least one risk factor. The main risk factors associated were metabolic disease, cardiovascular disease, and diabetes. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
5. [Vaccination against community acquired pneumonia in adults. Update 2021 of the position paper by Neumoexpertos en Prevención Group].
- Author
-
Redondo E, Rivero-Calle I, Mascarós E, Yuste JE, Fernández-Prada M, Ocaña D, Jimeno I, Gil A, Molina J, Díaz-Maroto JL, Linares M, and Martinón-Torres F
- Subjects
- Adult, Humans, Pneumococcal Vaccines, SARS-CoV-2, Vaccination, COVID-19, Community-Acquired Infections prevention & control, Pneumonia, Pneumococcal prevention & control
- Abstract
Community-acquired pneumonia (CAP) continues to be an important cause of morbidity and mortality in adults. The aim of this study is to update the practical prevention guide for CAP through vaccination in Spain developed in 2016 and updated in 2018, based on available vaccines and evidence through bibliographic review and expert opinion. The arrival of COVID-19 as a new cause of CAP and the recent availability of safe and effective vaccines constitutes the most significant change. Vaccines against pneumococcus, influenza, pertussis and COVID-19 can help to reduce the burden of disease from CAP and its associated complications. The available evidence supports the priority indications established in this guide, and it would be advisable to try to achieve a widespread dissemination and implementation of these recommendations in routine clinical practice., (Copyright © 2021 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
6. [The new official vaccine calendar for adults does not include the prevention of pneumococcal pneumonia].
- Author
-
Redondo E, Rivero-Calle I, Mascarós E, Díaz-Maroto JL, Linares M, Gil A, Molina J, Jimeno I, Ocaña D, Yuste JE, and Martinón-Torres F
- Subjects
- Adult, Age Factors, Aged, Humans, Pneumococcal Vaccines therapeutic use, Spain, Immunization Schedule, Mass Vaccination, Pneumococcal Infections prevention & control
- Published
- 2019
7. [Adult community acquired pneumonia vaccination: 2018 Update of the positioning of the Pneumonia Prevention Expert Group].
- Author
-
Redondo E, Rivero-Calle I, Vargas DA, Mascarós E, Díaz-Maroto JL, Linares M, Gil A, Molina J, Jimeno I, Ocaña D, Yuste JE, and Martinón-Torres F
- Subjects
- Adult, Community-Acquired Infections prevention & control, Humans, Influenza, Human prevention & control, Pneumonia, Pneumococcal epidemiology, Practice Guidelines as Topic, Spain, Influenza Vaccines administration & dosage, Pneumococcal Vaccines administration & dosage, Pneumonia, Pneumococcal prevention & control
- Abstract
Community-acquired pneumonia (CAP) continues to be an important cause of morbidity and mortality in adults. The aim of this study is to update the 2016 practical prevention guidelines for CAP through vaccination in Spain, based on the available vaccines, as well as the evidence using a literature review and expert opinion. Vaccines against pneumococcus and influenza continue to be the main prevention tools available against CAP, and can contribute to reduce the burden of disease due to CAP and its associated complications. The available evidence supports the priority indications established in these guidelines, and it would be advisable to try to achieve a widespread dissemination and implementation of these recommendations in routine clinical practice., (Copyright © 2018 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
8. [Vaccination against community acquired pneumonia in adult patients. A position paper by Neumoexpertos en Prevención].
- Author
-
Redondo E, Rivero I, Vargas DA, Mascarós E, Díaz-Maroto JL, Linares M, Valdepérez J, Gil A, Molina J, Jimeno I, Ocaña D, and Martinón-Torres F
- Subjects
- Adolescent, Adult, Aged, Community-Acquired Infections prevention & control, Humans, Middle Aged, Seasons, Spain, Young Adult, Influenza Vaccines administration & dosage, Influenza, Human prevention & control, Mass Vaccination methods, Pneumococcal Vaccines administration & dosage, Pneumonia, Pneumococcal prevention & control, Pneumonia, Viral prevention & control
- Abstract
Introduction: Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality in adults. The annual incidence of CAP in adults in Spain ranges from 3 to 14 cases per 1,000 inhabitants. Current clinical guidelines primarily focus on the therapeutic approach to CAP rather than its prevention. The aim of this study is to develop and propose a practical guide for CAP prevention through vaccination in Spain according to available vaccines and evidence., Methods: A literature review and expert opinion., Results: Pneumococcal and influenza vaccines are the main preventive tools available against CAP. Age, chronic diseases, and immunosuppression are risk factors for pneumonia, so these populations should be a priority for vaccination. In addition, influenza and pneumococcal vaccination is considered advisable in healthy adults under 60 years of age, and anyone with risk condition for CAP, irrespective of age. The influenza vaccine will be administered seasonally, while pneumococcal vaccination can be administered at any time of the year., Conclusions: Vaccination against pneumococcus and influenza in adults can help to reduce the burden of CAP and its associated complications. The available evidence supports the priority indications set out in this guide, and it would be advisable to try to achieve a wide circulation and practical implementation of these recommendations., (Copyright © 2016 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.